Clinical Trial Update: 6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome [Phase 4]

View source ↗

Summary

A phase 4 clinical trial update evaluating the use of 6-Methyl-Prednisolone for treating Multiple Organ Dysfunction Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Organ Dysfunction Syndrome

Drugs mentioned

• 6-Methyl-Prednisolone (6-methylprednisolone)

Snippet

Sponsor: Hospital Universitario Principe de Asturias | Conditions: Multiple Organ Dysfunction Syndrome | Phase 4 | Status: UNKNOWN